| 1 |
Sakmár M, Ondrák L, Fialová K, Vlk M, Kozempel J, Bruchertseifer F, Morgenstern A. In vitro studies of 223Ra- and 225Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy. J Radioanal Nucl Chem 2023. [DOI: 10.1007/s10967-022-08742-y] [Reference Citation Analysis]
|
| 2 |
Chatterjee S, Czerwinski KR, Fitzgerald HA, Lakes AL, Liao Z, Ludwig RC, Mcbride KM, Vlasenko VP. Delivery of radiopharmaceuticals and theranostic agents: targeted alpha therapy. Novel Platforms for Drug Delivery Applications 2023. [DOI: 10.1016/b978-0-323-91376-8.00012-4] [Reference Citation Analysis]
|
| 3 |
Rojas J, Umretiya R, Molina-higgins M, Gawi A, Gobalakrishnan S, Zweit J. Encapsulation of 67Cu therapeutic radiometal in luminescent lanthanide phosphate core and core-shell nanoparticles. Applied Radiation and Isotopes 2022;186:110296. [DOI: 10.1016/j.apradiso.2022.110296] [Reference Citation Analysis]
|
| 4 |
Lemaître TA, Burgoyne AR, Ooms M, Parac-vogt TN, Cardinaels T. Inorganic Radiolabeled Nanomaterials in Cancer Therapy: A Review. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c01204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Holik HA, Ibrahim FM, Elaine AA, Putra BD, Achmad A, Kartamihardja AHS. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker. Molecules 2022;27:3062. [PMID: 35630536 DOI: 10.3390/molecules27103062] [Reference Citation Analysis]
|
| 6 |
Varani M, Galli F, Bentivoglio V, Signore A. Particles and nanoparticles in nuclear medicine: Basic principles and instrumentation. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00079-x] [Reference Citation Analysis]
|
| 7 |
Schultz MK, Pouget J, Wuest F, Nelson B, Andersson J, Cheal S, Li M, Ianzini F, Ray S, Graves SA, Chouin N. Radiobiology of Targeted Alpha Therapy. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00093-4] [Reference Citation Analysis]
|
| 8 |
Li RG, Napoli E, Jorstad IS, Bønsdorff TB, Juzeniene A, Bruland ØS, Larsen RH, Westrøm S. Calcium Carbonate Microparticles as Carriers of 224Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer. Curr Radiopharm 2021;14:145-53. [PMID: 33261548 DOI: 10.2174/1874471013666201201102056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Kleynhans J, Sathekge M, Ebenhan T. Obstacles and Recommendations for Clinical Translation of Nanoparticle System-Based Targeted Alpha-Particle Therapy. Materials (Basel) 2021;14:4784. [PMID: 34500873 DOI: 10.3390/ma14174784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Trujillo-Nolasco M, Morales-Avila E, Cruz-Nova P, Katti KV, Ocampo-García B. Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications. Pharmaceutics 2021;13:1123. [PMID: 34452084 DOI: 10.3390/pharmaceutics13081123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 11 |
Lankoff A, Czerwińska M, Walczak R, Karczmarczyk U, Tomczyk K, Brzóska K, Fracasso G, Garnuszek P, Mikołajczak R, Kruszewski M. Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part II. Toxicity, Pharmacokinetics and Biodistribution. Int J Mol Sci 2021;22:5702. [PMID: 34071854 DOI: 10.3390/ijms22115702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Pruszyński M, Walczak R, Rodak M, Bruchertseifer F, Morgenstern A, Bilewicz A. Radiochemical separation of 224Ra from 232U and 228Th sources for 224Ra/212Pb/212Bi generator. Appl Radiat Isot 2021;172:109655. [PMID: 33657491 DOI: 10.1016/j.apradiso.2021.109655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH. Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer. Cancers (Basel) 2021;13:779. [PMID: 33668474 DOI: 10.3390/cancers13040779] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 14 |
Toro-gonzález M, Peacock A, Miskowiec A, Cullen DA, Copping R, Mirzadeh S, Davern SM. Tailoring the Radionuclide Encapsulation and Surface Chemistry of La(223Ra)VO4 Nanoparticles for Targeted Alpha Therapy. JNT 2021;2:33-50. [DOI: 10.3390/jnt2010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Bergeron DE, Collins SM, Pibida L, Cessna JT, Fitzgerald R, Zimmerman BE, Ivanov P, Keightley JD, Napoli E. Ra-224 activity, half-life, and 241 keV gamma ray absolute emission intensity: A NIST-NPL bilateral comparison. Appl Radiat Isot 2021;170:109572. [PMID: 33461017 DOI: 10.1016/j.apradiso.2020.109572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
Alekseev I, Miroslavov A. Post-effects of radioactive decay in magnetite nano-crystals labelled with Auger- and internal conversion electron-emitters, alpha- and beta decay radionuclides. Radiation Physics and Chemistry 2020;177:109160. [DOI: 10.1016/j.radphyschem.2020.109160] [Reference Citation Analysis]
|
| 17 |
Gawęda W, Pruszyński M, Cędrowska E, Rodak M, Majkowska-Pilip A, Gaweł D, Bruchertseifer F, Morgenstern A, Bilewicz A. Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy. Nanomaterials (Basel) 2020;10:E2067. [PMID: 33092037 DOI: 10.3390/nano10102067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 18 |
Toro-gonzález M, Dame AN, Mirzadeh S, Rojas JV. Encapsulation and retention of 225 Ac, 223 Ra, 227 Th, and decay daughters in zircon-type gadolinium vanadate nanoparticles. Radiochimica Acta 2020;108:967-77. [DOI: 10.1515/ract-2019-3206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Czerwińska M, Fracasso G, Pruszyński M, Bilewicz A, Kruszewski M, Majkowska-Pilip A, Lankoff A. Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part I. Materials (Basel) 2020;13:E3875. [PMID: 32887308 DOI: 10.3390/ma13173875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 20 |
Silindir-gunay M, Karpuz M, Ozer AY. Targeted Alpha Therapy and Nanocarrier Approach. Cancer Biotherapy and Radiopharmaceuticals 2020;35:446-58. [DOI: 10.1089/cbr.2019.3213] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 21 |
Majkowska-Pilip A, Gawęda W, Żelechowska-Matysiak K, Wawrowicz K, Bilewicz A. Nanoparticles in Targeted Alpha Therapy. Nanomaterials (Basel) 2020;10:E1366. [PMID: 32668687 DOI: 10.3390/nano10071366] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 22 |
Khodadadi Yazdi M, Zarrintaj P, Hosseiniamoli H, Mashhadzadeh AH, Saeb MR, Ramsey JD, Ganjali MR, Mozafari M. Zeolites for theranostic applications. J Mater Chem B 2020;8:5992-6012. [PMID: 32602516 DOI: 10.1039/d0tb00719f] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 23 |
Reissig F, Zarschler K, Hübner R, Pietzsch HJ, Kopka K, Mamat C. Sub-10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy. ChemistryOpen 2020;9:797-805. [PMID: 32775141 DOI: 10.1002/open.202000126] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 24 |
Toro-González M, Dame AN, Foster CM, Millet LJ, Woodward JD, Rojas JV, Mirzadeh S, Davern SM. Quantitative encapsulation and retention of 227Th and decay daughters in core-shell lanthanum phosphate nanoparticles. Nanoscale 2020;12:9744-55. [PMID: 32324185 DOI: 10.1039/d0nr01172j] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 25 |
Czerwińska M, Bilewicz A, Kruszewski M, Wegierek-Ciuk A, Lankoff A. Targeted Radionuclide Therapy of Prostate Cancer-From Basic Research to Clinical Perspectives. Molecules 2020;25:E1743. [PMID: 32290196 DOI: 10.3390/molecules25071743] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 26 |
Datta P, Ray S. Nanoparticulate formulations of radiopharmaceuticals: Strategy to improve targeting and biodistribution properties. J Labelled Comp Radiopharm 2020. [PMID: 32220029 DOI: 10.1002/jlcr.3839] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 27 |
Alekseev I, Miroslavov A, Stepanova E. Post-effects of radioactive decay in ligands on biologically active transport platforms. Radiation Physics and Chemistry 2019;162:96-106. [DOI: 10.1016/j.radphyschem.2019.04.033] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 28 |
Kruijff RM, Raavé R, Kip A, Molkenboer-Kuenen J, Morgenstern A, Bruchertseifer F, Heskamp S, Denkova AG. The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier. Sci Rep 2019;9:11671. [PMID: 31406320 DOI: 10.1038/s41598-019-48298-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 29 |
Gott M, Yang P, Kortz U, Stephan H, Pietzsch HJ, Mamat C. A 224Ra-labeled polyoxopalladate as a putative radiopharmaceutical. Chem Commun (Camb) 2019;55:7631-4. [PMID: 31197298 DOI: 10.1039/c9cc02587a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 30 |
Toro-gonzález M, Dame AN, Mirzadeh S, Rojas JV. Gadolinium vanadate nanocrystals as carriers of α-emitters ( 225 Ac, 227 Th) and contrast agents. Journal of Applied Physics 2019;125:214901. [DOI: 10.1063/1.5096880] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 31 |
Severin AV, Vasiliev AN, Gopin AV, Vlasova IE, Chernykh EV. Dynamics of Sorption—Desorption of 223Ra Therapeutic α-Emitter on Granulated Hydroxyapatite. Radiochemistry 2019;61:339-46. [DOI: 10.1134/s1066362219030093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 32 |
Jeon J. Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials. Int J Mol Sci 2019;20:E2323. [PMID: 31083402 DOI: 10.3390/ijms20092323] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 33 |
Reissig F, Hübner R, Steinbach J, Pietzsch H, Mamat C. Facile preparation of radium-doped, functionalized nanoparticles as carriers for targeted alpha therapy. Inorg Chem Front 2019;6:1341-9. [DOI: 10.1039/c9qi00208a] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 34 |
Farzin L, Sheibani S, Moassesi ME, Shamsipur M. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions. J Biomed Mater Res A 2019;107:251-85. [PMID: 30358098 DOI: 10.1002/jbm.a.36550] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 35 |
Bisht G, Zaidi MGH, Kc B. In vivo Acute Cytotoxicity Study of Poly(2-amino ethyl methacrylate-co-methylene bis-acrylamide) Magnetic Composite Synthesized in Supercritical CO2. Macromol Res 2018;26:581-91. [DOI: 10.1007/s13233-018-6080-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 36 |
Holzwarth U, Ojea Jimenez I, Calzolai L. A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy. EJNMMI Radiopharm Chem 2018;3:9. [PMID: 29888318 DOI: 10.1186/s41181-018-0042-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 37 |
Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland ØS, Bønsdorff TB, Larsen RH. Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice. J Labelled Comp Radiopharm 2018;61:472-86. [PMID: 29380410 DOI: 10.1002/jlcr.3610] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 38 |
Kozempel J, Mokhodoeva O, Vlk M. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators. Molecules 2018;23:E581. [PMID: 29510568 DOI: 10.3390/molecules23030581] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 39 |
McDevitt MR, Sgouros G, Sofou S. Targeted and Nontargeted α-Particle Therapies. Annu Rev Biomed Eng 2018;20:73-93. [PMID: 29345977 DOI: 10.1146/annurev-bioeng-062117-120931] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 40 |
Toro-gonzález M, Copping R, Mirzadeh S, Rojas JV. Multifunctional GdVO 4 :Eu core–shell nanoparticles containing 225 Ac for targeted alpha therapy and molecular imaging. J Mater Chem B 2018;6:7985-97. [DOI: 10.1039/c8tb02173b] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 41 |
Mastren T, Radchenko V, Owens A, Copping R, Boll R, Griswold JR, Mirzadeh S, Wyant LE, Brugh M, Engle JW, Nortier FM, Birnbaum ER, John KD, Fassbender ME. Simultaneous Separation of Actinium and Radium Isotopes from a Proton Irradiated Thorium Matrix. Sci Rep 2017;7:8216. [PMID: 28811573 DOI: 10.1038/s41598-017-08506-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 42 |
de Kruijff RM, Drost K, Thijssen L, Morgenstern A, Bruchertseifer F, Lathouwers D, Wolterbeek HT, Denkova AG. Improved 225Ac daughter retention in InPO4 containing polymersomes. Appl Radiat Isot 2017;128:183-9. [PMID: 28734193 DOI: 10.1016/j.apradiso.2017.07.030] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 43 |
Piotrowska A, Męczyńska-Wielgosz S, Majkowska-Pilip A, Koźmiński P, Wójciuk G, Cędrowska E, Bruchertseifer F, Morgenstern A, Kruszewski M, Bilewicz A. Nanozeolite bioconjugates labeled with 223Ra for targeted alpha therapy. Nucl Med Biol 2017;47:10-8. [PMID: 28043005 DOI: 10.1016/j.nucmedbio.2016.11.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 44 |
Mokhodoeva O, Vlk M, Málková E, Kukleva E, Mičolová P, Štamberg K, Šlouf M, Dzhenloda R, Kozempel J. Study of 223Ra uptake mechanism by Fe3O4 nanoparticles: towards new prospective theranostic SPIONs. J Nanopart Res 2016;18. [DOI: 10.1007/s11051-016-3615-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 45 |
Męczyńska-Wielgosz S, Piotrowska A, Majkowska-Pilip A, Bilewicz A, Kruszewski M. Effect of Surface Functionalization on the Cellular Uptake and Toxicity of Nanozeolite A. Nanoscale Res Lett 2016;11:123. [PMID: 26935303 DOI: 10.1186/s11671-016-1334-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 46 |
Frenvik JO, Kristensen S, Ryan OB. Development of separation technology for the removal of radium-223 from decayed thorium-227 in drug formulations. Material screening and method development. Drug Dev Ind Pharm 2016;42:1215-24. [PMID: 26569601 DOI: 10.3109/03639045.2015.1118494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 47 |
de Kruijff RM, Wolterbeek HT, Denkova AG. A Critical Review of Alpha Radionuclide Therapy-How to Deal with Recoiling Daughters? Pharmaceuticals (Basel) 2015;8:321-36. [PMID: 26066613 DOI: 10.3390/ph8020321] [Cited by in Crossref: 117] [Cited by in F6Publishing: 123] [Article Influence: 14.6] [Reference Citation Analysis]
|
| 48 |
Rojas JV, Woodward JD, Chen N, Rondinone AJ, Castano CH, Mirzadeh S. Synthesis and characterization of lanthanum phosphate nanoparticles as carriers for (223)Ra and (225)Ra for targeted alpha therapy. Nucl Med Biol 2015;42:614-20. [PMID: 25900730 DOI: 10.1016/j.nucmedbio.2015.03.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
|
